Why the study?
Does the response to antihypertensive treatments and prevalence of complications differ between African Americans and European Americans?
Population
African Americans and European Americans with hypertension in the U.S.
Comparison
Antihypertensive therapy vs Comparison between African American and European…
Design
Review
Authors
Loading...
Caution against race-based restrictions on beta-blockers or ACE inhibitors; leaves open prospective validation of responses.
Does the response to antihypertensive treatments and prevalence of complications differ between African Americans and European Americans?
The review argues against using racial profiling to restrict or defer the use of beta-blockers and ACE inhibitors in African Americans with hypertension, highlighting that socioeconomic factors often confound racial differences in outcomes.
Kenneth Jamerson (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: